126 related articles for article (PubMed ID: 94534)
21. Serum tumor markers.
Klee GG; Go VL
Mayo Clin Proc; 1982 Feb; 57(2):129-32. PubMed ID: 6172679
[No Abstract] [Full Text] [Related]
22. [Significance of tumor markers in clinical oncology].
Gericke D; Drahovsky D
Med Klin; 1979 May; 74(19):701-9. PubMed ID: 88005
[No Abstract] [Full Text] [Related]
23. Diagnostic value of alpha 1-fetoprotein and beta-human chorionic gonadotropin in infancy and childhood.
Schneider DT; Calaminus G; Göbel U
Pediatr Hematol Oncol; 2001; 18(1):11-26. PubMed ID: 11205836
[TBL] [Abstract][Full Text] [Related]
24. Biochemical markers in gynaecological cancer.
Farrell RJ
Ir Med J; 1980 Aug; 73(8):285-6. PubMed ID: 6161106
[No Abstract] [Full Text] [Related]
25. [Tumor markers in oncological gynecology].
Vishnevskiĭ AS
Vopr Onkol; 1984; 30(8):23-34. PubMed ID: 6207663
[No Abstract] [Full Text] [Related]
26. [Tumor markers--possibilities and limitations].
Rose H; Saul G; Wolf G; Moldenhauer H; Kehrberg G
Radiobiol Radiother (Berl); 1984; 25(1):7-19. PubMed ID: 6203136
[No Abstract] [Full Text] [Related]
27. Tumour markers. Their role in clinical medicine.
Dearnaley DP; Coombes RC
Practitioner; 1981 Jun; 225(1356):839-49. PubMed ID: 6170974
[No Abstract] [Full Text] [Related]
28. [Immunological diagnosis of cancer].
Mach JP
Schweiz Med Wochenschr; 1975 Oct; 105(41):1301-7. PubMed ID: 56032
[TBL] [Abstract][Full Text] [Related]
29. [Serum markers in malignant diseases].
Peter HH
Med Lab (Stuttg); 1981 Nov; 34(11):262-71. PubMed ID: 6176842
[No Abstract] [Full Text] [Related]
30. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
Brown JE; Cook RJ; Major P; Lipton A; Saad F; Smith M; Lee KA; Zheng M; Hei YJ; Coleman RE
J Natl Cancer Inst; 2005 Jan; 97(1):59-69. PubMed ID: 15632381
[TBL] [Abstract][Full Text] [Related]
31. Tumour markers in ovarian cancer.
van Nagell JR
Clin Obstet Gynaecol; 1983 Aug; 10(2):197-212. PubMed ID: 6193919
[No Abstract] [Full Text] [Related]
32. Tumor markers. Key pieces to your cancer patient's clinical picture.
Ostchega Y; Culnane M
Nursing; 1985 Sep; 15(9):48-51. PubMed ID: 2410836
[No Abstract] [Full Text] [Related]
33. Tumor markers for the diagnosis, prognosis, treatment and follow-up of gynaecological tumors.
Ulsperger E; Karrer K
Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):33-43. PubMed ID: 2545372
[TBL] [Abstract][Full Text] [Related]
34. Tumor markers: value and limitations in the management of cancer patients.
Bates SE; Longo DL
Cancer Treat Rev; 1985 Sep; 12(3):163-207. PubMed ID: 2416441
[TBL] [Abstract][Full Text] [Related]
35. Tumor markers in testis tumors.
Kansu E
Turk J Pediatr; 1984; 26(1-4):277-83. PubMed ID: 6085661
[No Abstract] [Full Text] [Related]
36. Serum tumor markers.
Perkins GL; Slater ED; Sanders GK; Prichard JG
Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
[TBL] [Abstract][Full Text] [Related]
37. [Biologic markers of cancer. Towards a selective use for the detection and surveillance of malignant tumors].
Bellet D; Bidart JM
Rev Prat; 1989 Nov; 39(26):2350-4. PubMed ID: 2480633
[No Abstract] [Full Text] [Related]
38. Serum levels of alpha-fetoprotein, human chorionic gonadotropin and carcinoembryonic antigen in patients with primary intracranial germ cell tumors.
Arita N; Ushio Y; Hayakawa T; Uozumi T; Watanabe M; Mori T; Mogami H
Oncodev Biol Med; 1980; 1(4-5):235-40. PubMed ID: 6169060
[TBL] [Abstract][Full Text] [Related]
39. [Diagnostic criteria for the tumor markers of the body fluids].
Konishi K; Nakagawa S; Watanabe K; Takamura S
Rinsho Byori; 1983 Sep; 31(9):945-54. PubMed ID: 6198536
[No Abstract] [Full Text] [Related]
40. [Tumor markers in gynecologic malignancies].
Tojo S; Suzuki A; Fujii S; Ashitaka Y; Maruo T; Matsuura S
Gan No Rinsho; 1983 May; 29(6):678-83. PubMed ID: 6192268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
